264 related articles for article (PubMed ID: 30214442)
21. Ubiquitination and phosphorylation of the CARD11-BCL10-MALT1 signalosome in T cells.
Lork M; Staal J; Beyaert R
Cell Immunol; 2019 Jun; 340():103877. PubMed ID: 30514565
[TBL] [Abstract][Full Text] [Related]
22. Malt1 inactivation attenuates experimental colitis through the regulation of Th17 and Th1/17 cells.
Nakamura Y; Igaki K; Komoike Y; Yokoyama K; Tsuchimori N
Inflamm Res; 2019 Mar; 68(3):223-230. PubMed ID: 30564895
[TBL] [Abstract][Full Text] [Related]
23. CARD-BCL-10-MALT1 signalling in protective and pathological immunity.
Ruland J; Hartjes L
Nat Rev Immunol; 2019 Feb; 19(2):118-134. PubMed ID: 30467369
[TBL] [Abstract][Full Text] [Related]
24. Critical protein-protein interactions within the CARMA1-BCL10-MALT1 complex: Take-home points for the cell biologist.
Cheng J; Maurer LM; Kang H; Lucas PC; McAllister-Lucas LM
Cell Immunol; 2020 Sep; 355():104158. PubMed ID: 32721634
[TBL] [Abstract][Full Text] [Related]
25. A MALT1 inhibitor suppresses human myeloid DC, effector T-cell and B-cell responses and retains Th1/regulatory T-cell homeostasis.
Dumont C; Sivars U; Andreasson T; Odqvist L; Mattsson J; DeMicco A; Pardali K; Johansson G; Yrlid L; Cox RJ; Seeliger F; Larsson M; Gehrmann U; Davis AM; Vaarala O
PLoS One; 2020; 15(9):e0222548. PubMed ID: 32870913
[TBL] [Abstract][Full Text] [Related]
26. MALT-1 inhibition attenuates the inflammatory response of ankylosing spondylitis by targeting NF-κB activation.
Qin H; Wu T; Liu J; Wang G; Fan L; Wang B; Shen Y
Injury; 2021 Jun; 52(6):1287-1293. PubMed ID: 33827774
[TBL] [Abstract][Full Text] [Related]
27. MALT1-Deficient Mice Develop Atopic-Like Dermatitis Upon Aging.
Demeyer A; Van Nuffel E; Baudelet G; Driege Y; Kreike M; Muyllaert D; Staal J; Beyaert R
Front Immunol; 2019; 10():2330. PubMed ID: 31632405
[TBL] [Abstract][Full Text] [Related]
28. A patent review of MALT1 inhibitors (2013-present).
Hamp I; O'Neill TJ; Plettenburg O; Krappmann D
Expert Opin Ther Pat; 2021 Dec; 31(12):1079-1096. PubMed ID: 34214002
[TBL] [Abstract][Full Text] [Related]
29. MALT-1 shortens lifespan by inhibiting autophagy in the intestine of
Vérièpe-Salerno J; Podavini S; Long MJC; Kolotuev I; Cuendet M; Thome M
Autophagy Rep; 2023 Nov; 2(1):2277584. PubMed ID: 38510643
[TBL] [Abstract][Full Text] [Related]
30. Identification of an Ortholog of MALT1 from Shrimp That Induces NF-κB-Mediated Antiviral Immunity.
Wang H; Xiao B; Chen S; He J; Li C
Viruses; 2023 Nov; 15(12):. PubMed ID: 38140602
[TBL] [Abstract][Full Text] [Related]
31. Identification of Tensin-3 as a MALT1 substrate that controls B cell adhesion and lymphoma dissemination.
Juilland M; Alouche N; Ubezzi I; Gonzalez M; Rashid HO; Scarpellino L; Erdmann T; Grau M; Lenz G; Luther SA; Thome M
Proc Natl Acad Sci U S A; 2023 Dec; 120(52):e2301155120. PubMed ID: 38109544
[TBL] [Abstract][Full Text] [Related]
32. KLF5‑mediated expression of CARD11 promotes the progression of gastric cancer.
Li Q; Li S; Li Z; Xu H; Zhang W
Exp Ther Med; 2023 Sep; 26(3):422. PubMed ID: 37602310
[TBL] [Abstract][Full Text] [Related]
33. Dectin-1 signaling coordinates innate and adaptive immunity for potent host defense against viral infection.
Kim HW; Ko MK; Park SH; Hwang SY; Kim DH; Park SY; Ko YJ; Kim SM; Park JH; Lee MJ
Front Immunol; 2023; 14():1194502. PubMed ID: 37334361
[TBL] [Abstract][Full Text] [Related]
34. Translational Studies Using the MALT1 Inhibitor (
Di Pilato M; Gao Y; Sun Y; Fu A; Grass C; Seeholzer T; Feederle R; Mazo I; Kazer SW; Litchfield K; von Andrian UH; Mempel TR; Jenkins RW; Krappmann D; Keller P
J Immunother Precis Oncol; 2023 May; 6(2):61-73. PubMed ID: 37214210
[TBL] [Abstract][Full Text] [Related]
35. Proteolytic Activity of the Paracaspase MALT1 Is Involved in Epithelial Restitution and Mucosal Healing.
Wittner L; Wagener L; Wiese JJ; Stolzer I; Krug SM; Naschberger E; Jackstadt R; Beyaert R; Atreya R; Kühl AA; Sturm G; Gonzalez-Acera M; Patankar JV; Becker C; Siegmund B; Trajanoski Z; Winner B; Neurath MF; Schumann M; Günther C
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108564
[TBL] [Abstract][Full Text] [Related]
36. NFκB signaling in T cell memory.
Daniels MA; Luera D; Teixeiro E
Front Immunol; 2023; 14():1129191. PubMed ID: 36911729
[TBL] [Abstract][Full Text] [Related]
37. Drug-Resistance Mechanism and New Targeted Drugs and Treatments of Relapse and Refractory DLBCL.
Zhang J; Gu Y; Chen B
Cancer Manag Res; 2023; 15():245-255. PubMed ID: 36873252
[TBL] [Abstract][Full Text] [Related]
38. Expanding spectrum, intrafamilial diversity, and therapeutic challenges from 15 patients with heterozygous CARD11-associated diseases: A single center experience.
Urdinez L; Erra L; Palma AM; Mercogliano MF; Fernandez JB; Prieto E; Goris V; Bernasconi A; Sanz M; Villa M; Bouso C; Caputi L; Quesada B; Solis D; Aguirre Bruzzo A; Katsicas MM; Galluzzo L; Weyersberg C; Bocian M; Bujan MM; Oleastro M; Almejun MB; Danielian S
Front Immunol; 2022; 13():1020927. PubMed ID: 36405754
[TBL] [Abstract][Full Text] [Related]
39. Combining precision oncology and immunotherapy by targeting the MALT1 protease.
Mempel TR; Krappmann D
J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36270731
[TBL] [Abstract][Full Text] [Related]
40. Assignment of IVL-Methyl side chain of the ligand-free monomeric human MALT1 paracaspase-IgL
Han X; Levkovets M; Lesovoy D; Sun R; Wallerstein J; Sandalova T; Agback T; Achour A; Agback P; Orekhov VY
Biomol NMR Assign; 2022 Oct; 16(2):363-371. PubMed ID: 36094731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
